Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Read Article
News
2024
2023
Archive
Search news articles
February 5, 2015
CELLULAR RESEARCH UNVEILS MASSIVELY PARALLEL SINGLE-CELL SEQUENCING TECHNOLOGY; ANNOUNCES PARTNERSHIP PROGRAM FOR DRUG DISCOVERY AND DIAGNOSTICS
February 2, 2015
FLEXION THERAPEUTICS INITIATES PHASE 3 CLINICAL TRIAL OF FX006 IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
January 28, 2015
WIRED ARTICLE: THIS WEARABLE HELPS YOU QUIT SMOKING BY DOSING YOU WITH NICOTINE
January 8, 2015
ACHAOGEN ANNOUNCES PLAZOMICIN GRANTED QIDP DESIGNATION BY FDA
December 17, 2014
FLEXION THERAPEUTICS ANNOUNCES EXERCISE OF UNDERWRITERS’ OVER-ALLOTMENT OPTION AND CLOSING OF PUBLIC OFFERING OF COMMON STOCK
December 17, 2014
RELYPSA TO BE ADDED TO NASDAQ BIOTECHNOLOGY INDEX
December 16, 2014
RELYPSA ANNOUNCES STEPHEN D. HARRISON, M.A., PH.D., JOINS AS SENIOR VICE PRESIDENT AND CHIEF SCIENTIFIC OFFICER
December 15, 2014
RELYPSA ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR PATIROMER FOR ORAL SUSPENSION TO TREAT HYPERKALEMIA
December 2, 2014
EPIRUS BIOPHARMACEUTICALS REMICADE® BIOSIMILAR, INFIMAB™, LAUNCHES IN INDIA
December 2, 2014
AUDENTES THERAPEUTICS RAISES $42.5 MILLION IN SERIES B FINANCING
« Previous Page
1
…
98
99
100
101
102
…
118
Next Page »